A New Horizon In Atopic Dermatitis: Topical Therapy Latest Evidence & Potential Of A New Topical Treatment – Ordre des pharmaciens du Québec (OPQ)

After completion of the program, participants will be able to:

1. Identify the pathophysiology and prevalence of atopic dermatitis (AD), the role of current topical therapy and a newly available topical treatment for mild to moderate atopic dermatitis (AD).
2. Implement an AD treatment strategy that recognizes the effects of AD on patients’ quality of life and includes targeted topical treatment and realistic SMART goals (e.g. Specific, Measurable, Attainable, Relevant, Time-based).
3. Identify the importance of reducing flares or recurrence and reinforce the ongoing daily protection of the skin barrier to optimize AD long-term management.
4. Reinforce the importance of the appropriate application and use of topical treatment as part of an adherence strategy.
5. Improve counselling and patient education by encouraging the pharmacist’s role in monitoring prescribed topical AD therapy.